153 related articles for article (PubMed ID: 31365169)
1. ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT.
Bui CB; Le HK; Vu DM; Truong KD; Nguyen NM; Ho MAN; Truong DQ
Mol Carcinog; 2019 Nov; 58(11):1998-2007. PubMed ID: 31365169
[TBL] [Abstract][Full Text] [Related]
2. Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells.
Suryo Rahmanto Y; Jung JG; Wu RC; Kobayashi Y; Heaphy CM; Meeker AK; Wang TL; Shih IeM
J Biol Chem; 2016 Apr; 291(18):9690-9. PubMed ID: 26953344
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Targeting of
Huang M; Zeki J; Sumarsono N; Coles GL; Taylor JS; Danzer E; Bruzoni M; Hazard FK; Lacayo NJ; Sakamoto KM; Dunn JCY; Spunt SL; Chiu B
Cancer Res; 2020 Mar; 80(5):1024-1035. PubMed ID: 31900258
[TBL] [Abstract][Full Text] [Related]
4. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Peifer M; Hertwig F; Roels F; Dreidax D; Gartlgruber M; Menon R; Krämer A; Roncaioli JL; Sand F; Heuckmann JM; Ikram F; Schmidt R; Ackermann S; Engesser A; Kahlert Y; Vogel W; Altmüller J; Nürnberg P; Thierry-Mieg J; Thierry-Mieg D; Mariappan A; Heynck S; Mariotti E; Henrich KO; Gloeckner C; Bosco G; Leuschner I; Schweiger MR; Savelyeva L; Watkins SC; Shao C; Bell E; Höfer T; Achter V; Lang U; Theissen J; Volland R; Saadati M; Eggert A; de Wilde B; Berthold F; Peng Z; Zhao C; Shi L; Ortmann M; Büttner R; Perner S; Hero B; Schramm A; Schulte JH; Herrmann C; O'Sullivan RJ; Westermann F; Thomas RK; Fischer M
Nature; 2015 Oct; 526(7575):700-4. PubMed ID: 26466568
[TBL] [Abstract][Full Text] [Related]
6. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
7. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
[TBL] [Abstract][Full Text] [Related]
8. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(β-TRCP) in neuroblastoma cells.
Singh A; Rokes C; Gireud M; Fletcher S; Baumgartner J; Fuller G; Stewart J; Zage P; Gopalakrishnan V
Cancer; 2011 Nov; 117(22):5189-202. PubMed ID: 21523764
[TBL] [Abstract][Full Text] [Related]
10. Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.
Ochiai H; Takenobu H; Nakagawa A; Yamaguchi Y; Kimura M; Ohira M; Okimoto Y; Fujimura Y; Koseki H; Kohno Y; Nakagawara A; Kamijo T
Oncogene; 2010 May; 29(18):2681-90. PubMed ID: 20190806
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activity.
Hu A; Chen G; Bao B; Guo Y; Li D; Wang X; Wang J; Li Q; Zhou Y; Gao H; Song J; Du X; Zheng L; Tong Q
Clin Transl Med; 2023 Apr; 13(4):e1235. PubMed ID: 37186134
[TBL] [Abstract][Full Text] [Related]
12. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1.
Günes C; Lichtsteiner S; Vasserot AP; Englert C
Cancer Res; 2000 Apr; 60(8):2116-21. PubMed ID: 10786671
[TBL] [Abstract][Full Text] [Related]
13. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
Shi Q; Yu B; Zhang Y; Yang Y; Xu C; Zhang M; Chen G; Luo F; Sun B; Yang R; Li Y; Feng H
Cell Oncol (Dordr); 2023 Dec; 46(6):1763-1775. PubMed ID: 37466744
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation.
Liu L; Saldanha SN; Pate MS; Andrews LG; Tollefsbol TO
Genes Chromosomes Cancer; 2004 Sep; 41(1):26-37. PubMed ID: 15236314
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of hASH1 is associated with the retinoic acid-induced differentiation of human neuroblastoma cell lines.
Ichimiya S; Nimura Y; Seki N; Ozaki T; Nagase T; Nakagawara A
Med Pediatr Oncol; 2001 Jan; 36(1):132-4. PubMed ID: 11464865
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid and cAMP differentially regulate human chromogranin A promoter activity during differentiation of neuroblastoma cells.
Gaetano C; Manni I; Bossi G; Piaggio G; Soddu S; Farina A; Helman LJ; Sacchi A
Eur J Cancer; 1995; 31A(4):447-52. PubMed ID: 7576943
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells.
Love WK; Berletch JB; Andrews LG; Tollefsbol TO
Int J Oncol; 2008 Mar; 32(3):625-31. PubMed ID: 18292940
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
[TBL] [Abstract][Full Text] [Related]
19. ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma.
Pieraccioli M; Nicolai S; Pitolli C; Agostini M; Antonov A; Malewicz M; Knight RA; Raschellà G; Melino G
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7356-7361. PubMed ID: 29941555
[TBL] [Abstract][Full Text] [Related]
20. Telomere biology including TERT rearrangements in neuroblastoma: a useful indicator for surgical treatments.
Kawashima M; Kojima M; Ueda Y; Kurihara S; Hiyama E
J Pediatr Surg; 2016 Dec; 51(12):2080-2085. PubMed ID: 27793328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]